Loading provider…
Loading provider…
Internal Medicine Physician in San Francisco, CA
NPI: 1174794309Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get M.D. Rahul's Phone Numberphone_androidMobile
Get M.D. Rahul's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2025

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Feinberg School of Medicine
feinberg.northwestern.edu
Medical School
Until 2006
UCSF School of Medicine
medschool.ucsf.edu
Residency • Internal Medicine
2006 - 2009
Fellowship • Hematology and Medical Oncology
2010 - 2013
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 155 | 352 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 133 | 211 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 50 | 74 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 23 | 23 |
| 5 | 99441Physician telephone patient service, 5-10 minutes of medical discussion | 21 | 27 |
Authors: Emily Bergsland, Mallika Dhawan, Pamela Munster
Journal: JCO Precis Oncol
Publication Date: 2024-11-07
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer.
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Authors: Emily Bergsland, James Yao, Christine Hann, Himisha Beltran, Lauren Byers, Ana Aparicio
Journal: Oncologist
Lead Sponsor: Thomas Hope
Collaborators: Prostate Cancer Foundation, Gateway for Cancer Research, Conquer Cancer Foundation
Intervention / Treatment: PROCEDURE: Positron Emission Tomography (PET), DRUG: 68Ga-PSMA-11
Lead Sponsor: BioXcel Therapeutics Inc
Intervention / Treatment: DRUG: BXCL701 monotherapy, DRUG: BXCL701 plus Pembrolizumab
Lead Sponsor: Xynomic Pharmaceuticals, Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: Abexinostat, DRUG: Pazopanib